dexmedetomidine has been researched along with Chronic Lung Injury in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 15 (71.43) | 24.3611 |
2020's | 6 (28.57) | 2.80 |
Authors | Studies |
---|---|
Guo, C; Liu, Y; Shi, L; Wu, F; Xie, Y | 1 |
Chen, J; Qiu, J; Wang, R; Xie, Y | 1 |
Chen, X; Li, C; Liu, Y; Shao, Y; Wang, L; Zhao, W | 1 |
Liu, J; Liu, X; Lv, C; Shen, Q; Wang, L; Xu, G; Yu, Y; Zhou, Y | 1 |
Lv, Q; Meng, J; Wang, S; Yang, K; Yao, J | 1 |
Li, GC; Li, ZB; Qin, J | 1 |
Cai, Y; Hong, H; Huang, Q; Jin, Z; Lin, T; Xia, F | 1 |
Chen, H; Cheng, X; He, X; Yan, X; Zheng, W; Zhou, L | 1 |
Fang, ZX; Gao, H; Luo, ZY; Wang, WT; Xiang, BQ | 1 |
Chen, BH; Lin, LN; Tang, YN; Weng, CW; Xue, BB | 1 |
Chunfang, Z; Dunjin, C; Hong, Z; Xianbao, L; Xu, Z | 1 |
Guo, L; Jiang, L; Li, L; Qi, Z; Shen, J | 1 |
Li, R; Yao, W; Yu, J | 1 |
Liu, H; Liu, T; Wu, D; Yang, Y; Zhang, Q | 1 |
Alkan, M; Arslan, M; Bilge, M; Çelik, A; Erdem, Ö; Kavutçu, M; Kip, G; Kiraz, HA; Özer, A; Şıvgın, V | 1 |
Li, T; Li, Y; Liang, J; Xiao, J; Xie, C; Zhao, Z | 1 |
Meng, FM; Xue, FS; Zhang, JQ; Zhang, W | 1 |
Chen, CH; Huang, CJ; Tsai, PS; Wang, TY; Yang, CL | 1 |
Chen, J; Gu, J; Ma, D; Tao, G; Xia, P; Zhao, H | 1 |
Alver, A; Cekic, B; Ertürk, E; Geze, S; Imamoğlu, M; Mentese, A; Tusat, M; Yörük, MF; Yuluğ, E | 1 |
Li, N; Meng, Q; Song, X; Wu, X; Xia, Z; Zhan, L | 1 |
1 trial(s) available for dexmedetomidine and Chronic Lung Injury
Article | Year |
---|---|
[Effects of dexmedetomidine preconditioning attenuating remote lung injury of lower limb ischemia-reperfusion].
Topics: Dexmedetomidine; Humans; Interleukin-6; Interleukin-8; Lower Extremity; Lung Injury; Reperfusion Injury; Tourniquets; Tumor Necrosis Factor-alpha | 2014 |
20 other study(ies) available for dexmedetomidine and Chronic Lung Injury
Article | Year |
---|---|
Dexmedetomidine Attenuates Lung Injury in Obstructive Jaundice Rats Through PI3K/Akt/HIF-1α Signaling Pathway.
Topics: Animals; Dexmedetomidine; Jaundice, Obstructive; Lung Injury; Male; Phosphatidylinositol 3-Kinases; Rats; Rats, Wistar; Signal Transduction | 2019 |
The Effects of Dexmedetomidine in a Rat Model of Sepsis-Induced Lung Injury are Mediated Through the Adenosine Monophosphate-Activated Protein Kinase (AMPK)/Silent Information Regulator 1 (SIRT1) Pathway.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Body Temperature; Cytokines; Dexmedetomidine; Disease Models, Animal; Inflammation Mediators; Lung; Lung Injury; Male; Rats, Sprague-Dawley; Sepsis; Signal Transduction; Sirtuin 1; Survival Analysis | 2020 |
Dexmedetomidine alleviates lung injury in sepsis mice through regulating P38 MAPK signaling pathway.
Topics: Animals; Dexmedetomidine; Humans; Lung; Lung Injury; Mice; p38 Mitogen-Activated Protein Kinases; Sepsis; Signal Transduction | 2021 |
Dexmedetomidine alleviates non-ventilation associated lung injury via modulating immunology phenotypes of macrophages.
Topics: Aged; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Dexmedetomidine; Female; Humans; Lung; Lung Injury; Macrophages; Male; Middle Aged; NF-kappa B; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2020 |
Effect of Dexmedetomidine on Postoperative Lung Injury during One-Lung Ventilation in Thoracoscopic Surgery.
Topics: Blood Gas Analysis; Dexmedetomidine; Female; Humans; Lung; Lung Injury; Male; Middle Aged; One-Lung Ventilation; Postoperative Complications; Postoperative Period; Thoracoscopy | 2020 |
Dexmedetomidine Attenuates Lung Injury in Toxic Shock Rats by Inhibiting Inflammation and Autophagy.
Topics: Animals; Autophagy; Dexmedetomidine; Disease Models, Animal; Hypnotics and Sedatives; Inflammation; Lung Injury; Male; Rats; Rats, Sprague-Dawley; Shock, Septic | 2021 |
Dexmedetomidine preconditioning ameliorates lung injury induced by pulmonary ischemia/reperfusion by upregulating promoter histone H3K4me3 modification of KGF-2.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Cell Membrane Permeability; Dexmedetomidine; Endothelium, Vascular; Fibroblast Growth Factor 10; Histones; Jumonji Domain-Containing Histone Demethylases; Lung Injury; Male; Mice; Mice, Inbred C57BL; Promoter Regions, Genetic; Reperfusion Injury; Up-Regulation | 2021 |
Dexmedetomidine alleviates lipopolysaccharide-induced lung injury in Wistar rats.
Topics: Animals; Biomarkers; Cytokines; Dexmedetomidine; Disease Models, Animal; Female; Gene Expression Regulation; Inflammation Mediators; Lipopolysaccharides; Lung Injury; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction | 2017 |
[Effect of dexmedetomidine on renal injury induced by lung ischemia/reperfusion in mice].
Topics: Animals; Dexmedetomidine; Imidazoles; Interleukin-1beta; Kidney; Lung Injury; Male; Mice; Mice, Inbred C57BL; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2017 |
Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Dexmedetomidine; Extremities; Lung; Lung Injury; Male; Myeloid Differentiation Factor 88; NF-kappa B; Organ Size; Peroxidase; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4 | 2019 |
Dexmedetomidine reduced cytokine release during postpartum bleeding-induced multiple organ dysfunction syndrome in rats.
Topics: Animals; Cytokines; Dexmedetomidine; Female; Hemorrhage; Kidney; Liver; Lung Injury; Male; Multiple Organ Failure; Postpartum Period; Pregnancy; Rats | 2013 |
Effect of dexmedetomidine on lung ischemia‑reperfusion injury.
Topics: Animals; Bronchoalveolar Lavage; Dexmedetomidine; Interleukin-6; Lung; Lung Injury; Mitogen-Activated Protein Kinases; Myeloid Differentiation Factor 88; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
Effects of dexmedetomidine on the protection of hyperoxia-induced lung injury in newborn rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Animals, Newborn; Aquaporin 1; Cytokines; Cytoprotection; Dexmedetomidine; Disease Models, Animal; Hyperoxia; Inflammation Mediators; Lung; Lung Injury; Macrophages; Pneumonia; Pulmonary Edema; Rats, Sprague-Dawley | 2015 |
Dexmedetomidine protects from post-myocardial ischaemia reperfusion lung damage in diabetic rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Glutathione Transferase; Lung; Lung Injury; Male; Malondialdehyde; Myocardial Ischemia; Myocardial Reperfusion Injury; Random Allocation; Rats; Rats, Wistar | 2015 |
[The effect of dexmedetomidine on autophagy and apoptosis in intestinal ischemia reperfusion-induced lung injury].
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Caspase 3; Dexmedetomidine; Lung; Lung Injury; Microtubule-Associated Proteins; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2015 |
Dexmedetomidine protects against lung ischemia-reperfusion injury by the PI3K/Akt/HIF-1α signaling pathway.
Topics: Animals; Chromones; Dexmedetomidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypnotics and Sedatives; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Lung Injury; Male; Morpholines; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction | 2016 |
Protective effects of dexmedetomidine-ketamine combination against ventilator-induced lung injury in endotoxemia rats.
Topics: Animals; Anti-Inflammatory Agents; Dexmedetomidine; Disease Models, Animal; Drug Therapy, Combination; Endotoxemia; Hypnotics and Sedatives; Ketamine; Leukocytes; Lipopolysaccharides; Lung; Lung Injury; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Sprague-Dawley; Ventilators, Mechanical | 2011 |
Dexmedetomidine attenuates remote lung injury induced by renal ischemia-reperfusion in mice.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Depression, Chemical; Dexmedetomidine; Imidazoles; Immunohistochemistry; Intercellular Adhesion Molecule-1; Kidney Diseases; Lung Injury; Male; Mice; Mice, Inbred C57BL; Organ Size; Paraffin Embedding; Peroxidase; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2011 |
Use of dexmedetomidine to prevent pulmonary injury after pneumoperitoneum in ventilated rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Disease Models, Animal; Female; Lung Injury; Pneumoperitoneum, Artificial; Rats; Rats, Sprague-Dawley; Respiration, Artificial | 2012 |
Protective effects of dexmedetomidine on blunt chest trauma-induced pulmonary contusion in rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Bronchoalveolar Lavage Fluid; Contusions; Cytokines; Dexmedetomidine; Disease Models, Animal; Leukocyte Count; Lung; Lung Injury; Male; Microscopy, Electron, Transmission; Neutrophils; NF-kappa B; Rats; Rats, Sprague-Dawley; Thoracic Injuries; Wounds, Nonpenetrating | 2013 |